Concourse Financial Group Securities, Inc. Nektar Therapeutics Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$1.11 - $1.48 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$0.9 - $1.83 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$0.49 - $0.96 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.42 - $0.57 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$0.51 - $1.05 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$0.51 - $1.05 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$0.53 - $1.03 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$2.03 - $4.28 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$3.04 - $5.14 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$3.17 - $6.17 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$4.16 - $13.72 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$10.83 - $18.41 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.07 - $18.84 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.52 - $20.4 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$16.56 - $25.46 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$15.77 - $19.03 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $723 - $1,398	-50 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $793 - $1,156	50 New	50 $1,000
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $0 - $0	0 New	0 $0

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$15.1 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.5 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.93 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.74 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $178M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account